Our Pipeline

We match the right target with the right modality and execute experiments with rigor to accelerate a steady stream of therapies with transformative or curative potential.

Our pipeline is dynamic and diverse—most programs are first-in-class molecules that address areas of high unmet need across our core therapeutic areas: Oncology, Rare Genetics & Hematology, Neuroscience and Gastrointestinal and Inflammation. We have also established strategic investments in Plasma-Derived Therapies and Vaccines.